Avalon Biomedical (Management) Limited (“ABM” or together with its subsidiaries, the “Group”) is pleased to announce that the Avalon Photonics’ KangaLite Phototherapy System has received CE Certificate as a Class IIa medical device issued by TÜV Rheinland on Jun 19, 2020. The CE mark states conformity with the essential requirements of the MDD, granting KangaLite access to the European market.

KangaLite is designed to make the treatment of neonatal jaundice at home possible. It is a wearable phototherapy device which promotes kangaroo care as well as breast-feeding. More importantly, KangaLite offers an ideal option for home phototherapy during COVID-19 pandemic.